Global Spinal Devices & Biologics Market Research Report to 2027 – Featuring Arthrex, Captiva Spine and Cure Surgical Among Others –

May 6, 2022

DUBLIN–(BUSINESS WIRE)–The “Spinal Devices & Biologics Market Research Report by Type (Fracture Treatment, Motion Preservation, and Non-Fusion Technologies), Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to’s offering.

The Global Spinal Devices & Biologics Market size was estimated at USD 7,195.20 million in 2021, USD 8,376.66 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 16.59% to reach USD 18,078.76 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Spinal Devices & Biologics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Spinal Devices & Biologics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Spinal Devices & Biologics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Spinal Devices & Biologics Market?

4. What is the competitive strategic window for opportunities in the Global Spinal Devices & Biologics Market?

5. What are the technology trends and regulatory frameworks in the Global Spinal Devices & Biologics Market?

6. What is the market share of the leading vendors in the Global Spinal Devices & Biologics Market?

7. What modes and strategic moves are considered suitable for entering the Global Spinal Devices & Biologics Market?

Market Dynamics


  • Increasing prevalence of degenerative spine disorders and due to sedentary lifestyles
  • Surging demand for minimally invasive spine surgery
  • Growing technological advancements in spine biologics


  • Issues related to high price and unbalanced compensation policies


  • Rising demand for spinal implants and devices
  • Improvement in augmented & virtual reality, endoscopic surgery, and 3D printed implants for minimally invasive spine surgery


  • Unfavorable and ambiguity in reimbursement policies

Companies Mentioned

  • Acuity Surgical
  • Aesculap, Inc.
  • Affirmative Solutions, LLC
  • Alphatec Holdings, Inc.
  • Amedica Corporation
  • Arthrex, Inc.
  • Captiva Spine, Inc.
  • Cure Surgical
  • DePuy Synthes, Inc.
  • Exactech Inc.
  • Globus Medical, Inc.
  • Innovasis, Inc.
  • Integra LifeSciences Corporation
  • Invictus Medical, Inc.
  • K2M Inc.
  • Lattice Biologics Ltd.
  • LDR Holding Corporation
  • Medtronic Inc.
  • Nuvasive Inc.
  • Orthofix International N.V.
  • Stryker Corporation
  • TranS1 Inc.
  • Wright Medical Technology Inc.
  • Zimmer Biomet Holdings, Inc.

For more information about this report visit

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button